How many boxes of Niraparib should you take per day if you take 1 pill per day?
For adults with advanced epithelial high-grade ovarian, fallopian tube, or primary peritoneal cancer who have achieved a complete or partial response to first-line platinum-based chemotherapy as maintenance monotherapy, the recommended dose of niraparib is 200 mg orally once daily. For patients with a body weight ≥77 kg, a platelet count ≥150,000 platelets/L, and mild or no hepatic impairment, it is recommended to take niraparib 300 mg once daily. It is recommended to continue niraparib treatment until unacceptable toxicity or disease progression occurs.
Niraparib is approved as a monotherapy for the maintenance treatment of adult patients with advanced epithelial (FIGO stage III and IV) high-grade ovarian, fallopian tube, or primary peritoneal cancer who have a complete or partial response after completing first-line platinum-based chemotherapy and who initiate maintenance treatment with niraparib for advanced ovarian cancer no later than 12 weeks after the patient's most recent platinum-containing regimen. Niraparib should not be used in patients who have not recovered from hematologic toxicity from prior chemotherapy.
NiraparibThe original drug has been launched in China and is included in medical insurance, but it is only reimbursed for eligible patients. The price of common specifications100mg*30 pills per box may be more than 5,000 yuan. According to the prescription information, patients take 1 pill a day and about one box a month, but the patient needs to be under the guidance of a doctor and cannot adjust on his own. The original niraparib drug marketed overseas is more expensive than domestically. There are also generic niraparib drugs produced in other countries. Their pharmaceutical ingredients are basically the same as those of the original niraparib drug sold domestically and abroad. The price of 100mg*30 tablets per box produced by a Bangladesh pharmaceutical factory may be more than 1,000 yuan (the price may fluctuate due to exchange rates).
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)